In response to:

Don't Let Obama Kill "Pills for Profit"

aj59 Wrote: Jan 29, 2013 12:33 PM
Dear God, please let the liberal morons who voted for that POS be the first ones to need these drugs companies will no longer produce, thanks to obamacare.
hmiller Wrote: Jan 29, 2013 5:55 PM

Dear sir, it is impossible for a liberal to be a moron! Compare the liberal country's to the not-liberal. The Middle East is described as very conservative in the circles of academia, International media, and the nowledgeable. Oh - Israel is very liberal. Name an era when the USA was run by the so-called conservatism of Today's new Southern GOP! Certainly wasn't the good old days of the good Old South.
FletchforFreedom Wrote: Jan 29, 2013 6:01 PM
"Dear sir, it is impossible for a liberal to be a moron!"

You disprove that position with every post.

For example, any idiot referring to the Middle East as "conservative" in any useful context can have nothing buit fertilizer between their ears. Oh, that explains it. And if you think "the circles of academia" are where non-morons congregate, your disconect from reality is truly amazing.

I'm not sure what the "nowledgeable" have to say, but if you want to know what the "knowledgable" have to say, pay more attention here. You're take is idiotic.

As for when conservatism ruled, try the late 19th century - the most prosperous period in US history.
Delta Wrote: Jan 29, 2013 1:02 PM
I've said that about the idiotic animal rightists who don't want proposed new medications tested on animals before they're made available for human beings. Let THEIR families do the testing so that the rest of us will be safe. And challenged with that idea, most of the dolts have no response.

Biotech company Excelixis CEO George Scangos likes to quote oil wildcatter JP Getty when asked about his philosophy for success: “Get up early; work hard; find oil,” he deadpans.

And under the direction of dry-humored Scangos, the San Francisco-based company is drilling a lot of research holes, so to speak.

They have to: Success in the biotech industry is measured incrementally, not in big steps. It’s a cash-and-time intensive industry where success is painstaking, rare and, because of Obamacare and other regulatory burdens from the administration, likely to become even rarer.   

According to Plunkett Research, Ltd in 2010 it...

Related Tags: Obama
Saturday, May 18 | 10:02 PM ET
Saturday, May 18 | 10:02 PM ET
Saturday, May 18 | 10:02 PM ET
Saturday, May 18 | 10:02 PM ET